Crinetics Pharmaceuticals Inc (CRNX)

CapEx to Revenue

2.07%

Quarterly · Period ending:

CRNX logo

CRNX CapEx to Revenue

Latest reported2.07%
CRNX Quarterly CapEx/Revenue (0.00% → 2.07%)
High-resolution chart · PNG

CRNX capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Crinetics Pharmaceuticals Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
2.0742%
7.6393%
7.4339%
603.4965%
310.5723%
343.2133%
0%
0%
239.3484%
208.125%
0%
1,011.5607%
23.9879%
0.5972%
38.646%
148.9083%
139.6355%
2.7787%
1.6698%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.